How M&A Turns a Chemical Company Into a Tech Business

7 May 2026 · 54 min · 26 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Buyer-led M&A in chemicals—how to use deal thesis, valuation discipline, and integration planning to transform a legacy chemical company into a technology-enabled “chemicals as a service” business, including AI/software acquisitions and customer partnerships.

Guest backgrounds

Chandra Dev Mehta. Career in corporate development and strategy in the chemical sector at LyondellBasell, Honeywell, and now Hexion (global specialty chemicals). Previously spent ~10 years in investment banking/strategic advisory (New York and Asia), then ~10 years in-house.

Key claims

Closing is irrelevant without integration and value creation. Build-vs-buy is driven by time-to-market and de-risking commercialization. Deal thesis must be validated from IOI→LOI→close with “must-believes” and red/green flags. Integration leadership must be named early. Environmental/asbestos liabilities require early risk allocation.

Notable examples

Hexion’s acquisition of an AI business (“Smart Tech”) ~1.5 years ago; early customer “green shoots.” A prior LyondellBasell–Sasol “SaaShole” transaction structured as a win-win partnership/JV emphasizing governance.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Guest Introduction: Chandra Dev Mehta

3:40 to 6:44

Learn about Chandra Dev Mehta's background and his role in M&A at Hexion.

“What makes Dev's perspective so interesting is that he's not just running deals.”

The Transition from Chemical to Tech Company

6:44 to 9:50

Understand how a legacy chemical company can evolve into a technology-driven business.

“And that's where I focus on in a principal role with the main key driver being strategy, defining where we invest and focus from a deal standpoint.”

Building a Deal Thesis in Complex Industries

9:50 to 14:00

Explore the key considerations in building and executing a deal thesis in asset-heavy sectors.

“And then we have to diligently execute and focus on creating value from an integration standpoint and understanding the portfolio composition standpoint to achieve the outcomes that we want.”

Evaluating Buy vs. Build Strategies

14:00 to 15:00

Learn how companies assess the risks and benefits of acquiring versus building products.

“you have it from grounds up, but it also takes time.”

Challenges of Partnerships in M&A

15:00 to 16:00

Discover the complexities of forming partnerships in the chemical industry.

“There's essentially lower risk because you get maturity of your solution and two, speed market.”

Transforming Chemicals into Services

16:00 to 17:20

Understand how chemical companies can evolve into service-oriented businesses.

“where they can test us, we can test them, we can jointly learn and grow, especially for a product that is relatively new in the marketplace.”

Developing a Service-Oriented Business Model

17:20 to 18:20

Gain insights on transitioning from product sales to service models in chemicals.

“That's where we want to be as a business.”

Adapting Business Models for Customer Value

18:20 to 19:20

Learn how adapting business models can enhance customer value and profitability.

“than our competitors or even with other technology providers, because we can bring a lot of unique capabilities that neither pure technology providers can bring in or neither our competition can bring in.”

Going to Market with Partnerships

19:20 to 20:20

Explore the strategies for effectively going to market through partnerships.

“And then in the end, how do we create a win-win where they see the value, we see the value and we both get paid for it?”

Sourcing Deals in the Chemical Industry

20:20 to 22:00

Discover how to identify and source deals effectively in the chemicals sector.

“And that's why we feel driving that adoption with that model is a better pathway for us.”
Show all 26 chapters

Regional Factors in Deal Sourcing

22:00 to 23:40

Understand how regional dynamics influence deal sourcing strategies.

“And then also, how can we bring our domain knowledge to support them on a regular basis?”

Engagement with Banks and Inbound Opportunities

23:40 to 25:20

Learn how to leverage banking relationships for deal opportunities.

“For sourcing deals, we have had a multi-pronged approach.”

Evaluating Bank Pitches for M&A

25:20 to 27:00

Discover key factors that differentiate effective pitches from bankers.

“And secondly, is that adding more to our portfolio, which could be further enabled from an AI and a software standpoint.”

Becoming a Trusted Advisor in Banking

27:00 to 28:00

Learn the importance of deep knowledge and relationships in banking success.

“And everybody knows the companies out there, but what is your angle?”

Understanding Company Coverage in Banking

28:00 to 29:05

Learn the importance of focusing on a select number of companies in investment banking.

“I'm curious, if you were to go back to banking, how many companies would you try to cover?”

Valuation Dynamics from IOI to Close

29:05 to 30:50

Discover how to assess and validate opportunities throughout the M&A process.

“What moves valuation when you go from IOI to close?”

The Integration Phase in M&A

30:50 to 32:18

Understand how to prepare for integration right from the IOI phase in M&A.

“then any price you pay is not going to get you there.”

Navigating Auction vs. Proprietary Deals

32:18 to 33:59

Learn the differences in approach between competitive auction and proprietary deals.

“So that's why you need to name your integration leader early on, make sure that they have a buy-in into what you are looking to do, and they own it.”

Risk Allocation in Environmental Deals

33:59 to 35:15

Explore the challenges of environmental liabilities in chemical deals and how to mitigate them.

“But doing a deal for deal's sake is never a good idea.”

Deal Stories and Lessons Learned

35:15 to 38:10

Hear real-deal stories that highlight the complexities of M&A transactions.

“Environmental is obviously top on my list a lot of times.”

Governance Challenges in Joint Ventures

38:10 to 42:00

Understand the governance issues and negotiation points in joint ventures.

“And one of the deals, like I mentioned, had a lot of that components in it where a lot of it, we did not even know what we owned because it was such a small business in our broader portfolio.”

Navigating Joint Ventures

42:00 to 43:30

Learn the essential governance considerations when executing joint ventures.

“Especially when you're doing JV, sometimes you have to talk about divorce.”

Core Principles of M&A Execution

43:30 to 46:10

Explore the fundamental principles necessary for successful M&A execution.

“You spend 10 years of banking, 10 years in corp dev role.”

Building Trust in M&A Relationships

46:10 to 49:04

Understand the importance of trust and communication in M&A negotiations.

“IT, like I said, is also an important element of it because it's the backbone of a lot of companies.”

Challenges in International Deals

49:04 to 50:39

Examine the complexities of conducting M&A across different cultures.

“Then you can say, hey, look, we would have a different approach.”

Learning From M&A Experiences

50:39 to 51:48

Reflect on the unpredictable nature of M&A and the lessons learned.

“It all comes down to what is right then, but you just have to keep at it.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:01Chandradev Mehta:Hey M &A scientists, before we get started, we just launched the M &A fundamentals certification on DealPilot, and I'm really proud of this one. I was personally involved building it out with PhD learning development professionals. It covers the full M &A lifecycle, buy side, sell side, key terminology, and the buyer-led M &A framework, over 60 templates and artifacts, so you're not just learning concepts you can actually go execute this isn't one of those certifications that charges you thousands of dollars to teach you stuff you can find on wikipedia this is how i've actually trained people practical comprehensive and built from real deal experience it's all part of the m a science subscription and the next certification track is coming up in a couple months check it out at mascience.com all right let's get into it

0:58Chandradev Mehta:Listen up. The buyer-led M &A Summit is back. Last time, we had thousands of registrants to network with, some of the sharpest M &A minds in the industry sharing what's working in their programs and conversations people are still talking about. This time, we're building even bigger. May 20th, Dealroom is hosting the buyer-led M &A Summit, and the focus is AI and M &A, how leading corp dev teams are using it to source better deals, move faster through diligence, and execute integration with more precision. The practitioners on this agenda have done the work and they're coming to share specifics.

1:33Chandradev Mehta:I'm running a session on the foundations of ByerLead M &A, which I think is the best place to start before the day gets into the deeper stuff. From there, we go into AI and pipeline, a live look how diligence is changing, and a panel of corp dev leaders talking about what's working from their teams right now. free virtual 1130 to 130 eastern this podcast is part of how you stay sharp on mna the summit is the next step register at dealroom.net summit that's dealroom.net summit now back to the episode

2:13Chandradev Mehta:i'm kisan patel and you're listening to mna science where we talk with deal professionals and learn valuable lessons from their experience. This podcast focuses on stories, strategies, and what actually happened during M &A deals.

2:37Chandradev Mehta:Hello M &A scientists, welcome to the M &A Science Podcast. This show is part of our mission to rethink how M &A is done and build the operating standard for BuySide M &A, that old school, seller-led approach, dead. BuySide M &A is about strategy, alignment, and execution, putting value creation at the center of every deal. It's not just about closing the deal. It's about making it successful. And where that comes from learning directly from the operators who've done it before. If you want to go deeper, we got you covered. There's tons of free resources on our website, frameworks, guides, tools, all built from real operator experience.

3:17Chandradev Mehta:We also have the M &A Science membership, which gives you the full system, frameworks, templates, expert Q &A sessions, direct access to me, and the AI-powered intelligence hub. If you just want to stay sharp, sign up for a free newsletter. That's how to keep up with everything that's happening in M &A. You can find all of this at mascience.com. Again, that's mascience.com. Let's jump into it. I'm your host, Kisan Patel. Today I'm joined by Chandra Dev Mehta. He spent his career leading corporate development and strategy at major players in the chemical sector, including Lionel Bissell, Honeywell, and he's now driving M &A and business development at Hexion, a global specialty chemicals company.

4:02Chandradev Mehta:What makes Dev's perspective so interesting is that he's not just running deals. He's using M &A to answer a fundamental strategic question. How does a legacy chemical business evolve into a technology-driven company? That's a challenge a lot of industrial encumbrance are wrestling with right now. And that's what Dev has real experience navigating. So today we're going to talk about how to build and execute a deal thesis in a complex, asset-heavy industry, and how valuation, negotiation, and strategy alignment play out differently when M &A is being used to fundamentally reshape where your company is.

4:40Chandradev Mehta:Dev, how are you doing today? I'm good, Kishan. How are you? Thanks for taking the time from doing deals to have a conversation with me. Can we kick things off a little bit about your background? I've done investment banking for about 10 years, working with clients on their capital needs, but more importantly, M &A and strategic advisory. I've worked in New York and Asia as well. So I've seen more of a global phenomenon in terms of cross-border M &A, as well as focusing on strategic needs that drive M &A and investment. And then for the last 10 years, I've been on the corporate development side, running strategy corporate development for companies like Lionel, Buzel, Honeywell, and now with Hexion, where we are seeing M &A as a tool to accelerate our focus on strategy and portfolio shaping.

5:22I'm happy to be here and share my thoughts with your audience.

5:25Chandradev Mehta:So that's like 10 years investment banking. We've probably got a lot of reps in on deals, 10 years in-house. How would you contrast the experience or the difference in those roles? Do you sort of have like empathy with the bankers and the deals you work with? Or do you look at them as points of friction? Yeah, I've been on both sides. I think it's a little bit of a different role. On a banking side, you are more of an advisor, supporting your clients and guiding them. Whereas in a principal role, you are making things happen. One big realization on the principal side has been is that you can execute a really strong deal.

5:58You can get a really good price for it. But unless you integrate that transaction and create the synergies and create the value that you have put into your deal thesis, everything is irrelevant. So spending more time on thinking through strategy, thinking through the Fed, thinking through the value creation levers, and how do you accelerate them to achieve the outcomes you want? That is the focus being on the principal side. And that's what excites me in that role.

6:23Chandradev Mehta:Strategies, synergy, all the way through execution. And you got to be on point. You can't miss. Absolutely. And everything comes down to value at the end of the day. But more importantly, how do you think about how are you going to line up your supply chain? How are you going to line up your procurement? How is the IT system going to have the backbone? How are you going to focus on from a commercial standpoint? A lot of those levers become important from a value standpoint. And that's where I focus on in a principal role with the main key driver being strategy, defining where we invest and focus from a deal standpoint.

6:53Chandradev Mehta:In the last 10 years, going from Honeywell to Hexion, has just your philosophy or even just the way you think about M &A has evolved or changed? Yeah, look, again, it depends on where the company's strategy is, where do we want to focus on. At Hexion, I can tell you that we are a chemicals company, but we are transitioning more into a technology-focused chemicals as a service enablement business. We actually acquired a business in the AI space, Smart Tech, a year and a half back. And we are in the process of integrating where we bring the world of chemical as well as the world of technology to say, how can we create more value?

7:29Not for us, but more importantly, for our customers. How can we give them more through that transaction? And integrating that and leveraging that to get to the next level has been the core focus for me. It is bringing together M &A as a tool to accelerate our focus on strategy for becoming chemistry as a service for Exxon.

7:47Chandradev Mehta:Let's break that down. Can you walk me through? Because it sounds easier said than done. Hey, we want to evolve, be more of a tech company. This hits a lot of industries, even there's seen in services that we want to become more of a tech company. Give me the basics of going from that strategy to execution. What makes it hard? As we thought about strategy, the commodity chemical sector is obviously pretty challenged. And you're always a price taker versus being able to differentiate yourself. And we have some differentiating products and we'll continue to do that. But more importantly, as you think about M &A as a tool to accelerate strategy, we had looked at it and said, if we can acquire a business that has a technology element to that, combining that with our chemical portfolio, now you can certainly create a lot more value from a close integration standpoint.

8:29M &A became a tool to accelerate that strategy that we have put forth and bringing on a business that is in the technology space, but not so much in the chemical space. We have our chemicals portfolio saying, okay, how can we integrate those two where we leverage the toolkit that we got from the new business? We understand the customer requirements as well. We also understand in terms of how we can bring our domain knowledge of the sector to leverage the AI and the tools that we have acquired for the new business and layering in that domain knowledge to accelerate the product development, having a better product roadmap to achieve the outcomes that are important for our customers.

9:09And that's why we also went and did like a VOC to understand what are the pain points for our customers, where are they needing more help, how can we drive more efficiency for them, how can we drive and manage more costs for them, which will create value, which eventually everybody gets benefit from. Bringing out our experience, our portfolio, our domain knowledge, along with the technology toolkit that we acquired, that kind of gives the whole bandwidth from a portfolio standpoint that we can provide to our customers that drives outcomes for them. And that's what we have been doing. I mean, it's early days and we have a lot more work to do.

9:42But again, this is an example where strategy leads where we focus on. M &A becomes the tool to execute on that strategy. And then we have to diligently execute and focus on creating value from an integration standpoint and understanding the portfolio composition standpoint to achieve the outcomes that we want. That's why the whole life cycle becomes important here. And it hasn't been done before. If you go and look at the other chemical companies, not a lot of them are focused on technology and AI. And we are trying to be unique in that manner because we can afford, we are a niche player that can have technology enable our products to a different level.

10:19And we have that ability to do so. And that's what we are going to continue to accelerate our efforts on.

10:24Chandradev Mehta:I'm kind of curious just from the beginning, how the strategy shapes. I know you mentioned quite a few different elements here. You have your existing business portfolio. Leo, you have the technology, essentially your tech toolkit that you're acquiring. You have this customer requirements slash voice of the customer, and then your domain knowledge and how you can leverage it to bring these things together on the technology acquisition. Like, where does that start? If you look at it, is it, here's a business strategy that we came up with and how does that evolve and shift? Or is it more bottoms up with these conversations through the customer?

10:55Chandradev Mehta:How do you sort of get to that point where you can build a deal thesis on what kind of business you need to acquire to make it happen? I think it is both ways. Some of it is you need to understand the customer pain points and understand what are their challenges. Again, this is a sector which has been challenged because a lot of exposure is around building and construction markets, which are subdued right now. And so as you think about talking to the customers, their focus is on how can we drive more efficiency? How can we drive more throughput? How can we drive more cost management? And then we go and look at our portfolio in terms of what can we provide that can service those needs.

11:28And there is only so much we can do sitting with our current portfolio. But as we looked at it, we said, okay, if you enable some of this with technology, if you can enable this with more AI enablement where you are providing more predictive analytics, you are providing more agentic analytics, we said, okay, if you layer in that along with our portfolio, that certainly starts to become more meaningful for our customers. And then it became a discussion on build versus buy on how do we achieve that outcome. We looked at doing more internal building as well in terms of how can we build those capabilities, build that awareness in terms of product development.

12:02We looked at that, but we also looked at is there a positive way to get to market through a potential transaction, potential acquisition, even a partnership. We looked at different options to achieve that outcome. And it just so happened that we were able to find a company that suited our capabilities, that was aligned with what we were trying to do. They were trying to penetrate in that space. And we felt that combining our business with theirs would certainly accelerate the efforts. And it is one plus one equals four and not just one plus one equals two. And that's why we decided to move from an M &A standpoint instead of trying to build it ourselves.

12:36And this also accelerates our go-to-market. And we have already been deploying that product with our customers. We have been already seeing some early green shoots in terms of success.

12:44Chandradev Mehta:So this isn't just moonshot bets. there's some validation with these customer conversations. Yes. By bringing in these features and capabilities, you're going to have some unique benefits that you provide your customers. So that's where you start shaping your strategy around that. And then the deal thesis, what precedes it is this build versus buy versus partner analysis. Right. Can we talk to you a little bit more about that? It seems like a tread lightly across it or like how much depth do you actually have in doing that analysis? And then when do you sort of really get that? Because you even mentioned you found that right fit of a company.

13:16Chandradev Mehta:Versus you can almost easily say, hey, let's just buy it. I want to solve the problem faster through an acquisition versus using the other means. Yeah, every opportunity has to be evaluated on its own merit, as I see it. And we have done that in different ways. And there are places where we have gone and built it ourselves too. It all depends on what are your core capabilities as a company, as a business. What do you bring to the table that can help you develop that product set? Are there opportunities out there that are actionable? because you have to find a company that is one actionable, that aligns with what you're looking to do, and it actually accelerates your efforts and not just pushes you back from a development standpoint.

13:53The stars have to align for you to go in one direction versus another. The easiest answer is to obviously build it ourselves because when you build it yourself, you know what you're doing, you have it from grounds up, but it also takes time. It also takes effort. There is also a risk of getting to commercialization, whereas if you look at buying a business which has already been commercialized or at least close to getting commercialized, you de-risk a lot of your go-to-market strategy and you are already more than halfway there. Plus, there is already a product that is far advanced from a development standpoint.

14:23So the timing-wise, also you are much more advanced. And as we looked at it, we felt that go-to-market and speed-to-market is important. And when we found an opportunity that kind of fitted with a lot of our requirements, nothing is 100 % accurate, but as it fits with most of our requirements, we thought that we could, with our capabilities, we could certainly enhance the product, enhance their capabilities, and we would be a better owner of that business to be able to go to market a lot quickly than we would do if we have to build it ourselves. And we looked at partnerships as a third angle, but partnerships was just challenging given the nature of the market space.

14:59So buying versus build became the right answer. And then it came down to time versus resources versus de-risking one versus another, especially when we found an opportunity that was actionable, that fitted out requirements, it just became an easier conversation to move towards buying and integrating that quickly.

15:17Chandradev Mehta:So buy versus build, I get. There's essentially lower risk because you get maturity of your solution and two, speed market. That sounds clear. On the partnerships, I'm curious about because I feel like things are evolving where even the marketplace is getting more partner-friendly where you can essentially license IP, be able to leverage it that way without having to take a big cost of doing the acquisition and a lot of the overhead and time that goes with it. Do you see that shifting at all? We are looking at partnerships too. We have actually put in place partnerships with our customers to drive more adoption.

15:49That's one way where we see partnerships as a great tool because we have the product, we can partner with them to co-develop, co-join in terms of drive more adoption. And that's where we feel partnerships are valuable where they can test us, we can test them, we can jointly learn and grow, especially for a product that is relatively new in the marketplace. And that's the one where we feel partnerships are a great tool. And we have already had two or three different partnerships that are in play right now with different customers, drive more co-development and co-adoption. So we look at all the different levers that make sense for us from an engagement standpoint.

16:25And the acquisition of the software and the AI was the right way to do it. Partnerships in terms of driving more adoption is the right method we feel. So that's why we are doing it both ways.

16:34Chandradev Mehta:Can we talk through putting this together? Walk me through what chemicals as a service looks like. What are the options on the table? How did you actually get there? Chemicals as a service means, again, understanding what are the pain points of the customers. Right now, all we do is just sell our residents into the marketplace. But with a service, you are not just selling a product. You are providing them a service where it is helping them make their operations more efficient, helping them drive more growth from a top-line standpoint, also driving more of their cost management. So you are becoming a partner with your customers in terms of helping them scale better, helping them drive to better margins, while also you benefiting in the interim because you're also kind of engaging more regularly with the customers versus earlier where you were just selling the product and then that was it.

17:22It creates a more of an aftermarket deal for us with the customers, allows us to monetize our install base better, allows us to be more closer to our customers and then be more of a service provider that is working jointly with our customers instead of just being a supplier of a product. And that's where we see long-term as our future, as our business future in terms of being more of a, not just a supplier of product, but being more of a partner with our customers in terms of helping them solve their problems and helping them across the value chain to drive more efficiencies and create value for both of us in the meantime.

17:54That's where we want to be as a business. That's where we want to be as a company. And we feel that being in this business of providing more of a service that is the right place for us to be, given our capabilities, our domain knowledge, our ability to understand the customer set. We are also one of the largest players in the sector. We have a much more broader penetration of where the market is. We also understand the customers better. And again, that makes us a lot more unique in terms of being able to monetize this better than our competitors or even with other technology providers, because we can bring a lot of unique capabilities that neither pure technology providers can bring in or neither our competition can bring in.

18:33And there's a very significant edge of being able to drive this much better with our customer pool.

18:38Chandradev Mehta:How do you think about the implications to the business model? Because you went from traditional chemicals where you're essentially selling a product to now services, looking at more reoccurring revenue. Is there an impact on valuation when you think about that? Yeah, the business model is undergoing change and that is changing across the industry as we speak in some ways too. and we are all trying to adapt and adopt. Things are, again, I would say early stages and we want to try and do more of, but in terms of how do we drive the mentality from a customer standpoint too, they are not used to paying for that service today.

19:10How do we make sure that they understand that value where they pay for that service? How can we bring that value up front to the customers so they see that value that they are going to pay for? And then in the end, how do we create a win-win where they see the value, we see the value and we both get paid for it? So that business model is evolving. And that's why the partnership model is important because now you are jointly learning some of those nuances and then developing some of that model and the thesis together, which is exactly what we want to do. It is not just we want to go to the customers and say, this is our model and take it.

19:42It is more about how can we work with you, develop a win-win model that works for both of us. And that's why driving adoption through partnerships is one of the right ways for us to go to market. And that's what we are pursuing.

19:54Chandradev Mehta:Can you define what that means to go to market through a partnership versus how you'd otherwise go to market? So otherwise you can go to market as I can call the customers and say, this is the service we are providing and just buy. That's one way to do it. Where we are going to the customers and saying, look, this is what we can bring to the table. This is what you can bring to the table. How can we work together to develop the thesis that we have, the product that we have to jointly create value for both of us? And that's why it drives adoption better because the customers feel that they also have a skin in the game of evaluating and jointly developing it with us versus just taking a product and testing it on their side.

Read the full transcript

20:30And we also feel that instead of just selling a product which may not be fully there, this allows us to also co-develop and have a product which is more attuned to customer needs and addresses their problems more so than selling them a solution which may or may not get them there.

20:45Chandradev Mehta:It is a win-win for both of us. And that's why we feel driving that adoption with that model is a better pathway for us. Are the commercial terms different in that approach or is it more of just the relationship framing? Commercial terms will also be different. You're just selling a product versus selling a service. So the commercial terms will be different as we see the software as a service that has been out there. I mean, there are different ways to go to market on selling that software. How do you drive more recurring revenue? How do you drive more adoption? How do you drive more margin development?

21:14How do you drive your product roadmap to make sure that is staying current with the customer needs? A lot of those things which we are not doing today from our product selling standpoint will come into play as we get more on the servicing side. So all of that will change.

21:27Chandradev Mehta:Commercial terms will change. I guess I was looking at the framing of working with the customers instead of saying, hey, I'm selling you this solution. We're sort of approaching you as a partner and providing this solution. Does that sort of framing lend to different commercial terms? Absolutely. And that's exactly where it is, because now we are talking on different levels. We are not just selling them a resin, we are selling them a service. We are selling them service which can help them improve their efficiency. So some of that might be tied to their value metrics. Some of them might also be tied to how can we help them drive more efficiency and accelerate their efforts.

22:00And then also, how can we bring our domain knowledge to support them on a regular basis? Everything will change in that manner where it is not just the commercial terms, but also our engagement. Now we are going to be a lot more closely tied with our customers. How are we going to provide them with the aftermarket servicing? As we understand more of the data set for a broader customer, how can we use that data to influence how we drive more AI enablement for these products? That is something that we will have to continue to keep doing on our side as we engage with these customers because it will benefit them to look at the various data pool out there and how that can change what they are trying to do with their product.

22:37Chandradev Mehta:And I understand this whole relationship framing is completely different with the depth of relationship that you're acting on, how you're building that relationship to make the value tangible, the metrics that you're trying to align with on the customer. Now that makes sense of why the partnership framing. Yeah, and I think you have to partner not just with the end users, but also with the service providers, with the system integrators, because a lot of those players are also as part of the ecosystem. We are trying to partner with different stakeholders and different players to make sure that we can create value through different routes.

23:05It is not just going to the end user and saying, I want to just partner with you, but it is also partnering with the OEMs that are supplying into the marketplace. There are the players who are in the sensor space that are also a big player supplying into the marketplace. There are system integrators that provide these larger systems for the end users. And how can you work with them to make sure that you are providing that service through them? So it is a partnership at a multifaceted level that will help us penetrate the marketplace much better.

23:32Chandradev Mehta:Awesome. Let's talk about execution. What does that look like in terms of finding these opportunities? We can talk about how to evaluate them, but how do you like, what's this model look like for sourcing deals? For sourcing deals, we have had a multi-pronged approach. We are going to our customers and showcasing them what we can bring, how we can bring, how we can create value for them. Because that is the pull side of the equation where the customers have to feel the pull to have this. And then there is a push with the OEMs and our partners to say, look, this is the service and the software service that you should enable along with your products because it is going to create a lot more value for your customers.

24:06And that will also help you differentiate in the marketplace as you win these contracts. That's the push element of it. And then there is a pull element of it. So we are working on both fronts to identify and deal source and saying, okay, one or the other is not going to be enough. So making sure that we are working the partnership angle to push, whereas also working with the end user angle to pull and driving the deal sourcing from both sides is what we are looking to do. And again, some of it is also regional based. U.S. versus Europe versus Asia. The dynamics are very different. Asia has a very crowded marketplace in terms of how they play there.

24:37More local players, smaller players. Europe has larger players, more family-owned businesses, mainly doing it through partnerships. And U.S. is more direct end users driving decisions. So regional layer, as we do more deal sourcing, also comes in play. It is complicated and challenging, and it is not just a straightforward answer.

24:54Chandradev Mehta:Well, you described a lot of angles that are proprietary deal sourcing from these customer conversations through your own research. Is there anything that comes in through bank process, inbound, stuff like that that you're acting on? Is most of it all proprietary deals? From the deal standpoint, we get opportunities to look at either services that we can attach to this one that are companies that are either developing products or developing services that are in that ecosystem that might be a good add on to what we are trying to do. And secondly, is that adding more to our portfolio, which could be further enabled from an AI and a software standpoint.

25:27So those are the two areas where we feel we get inbounds from bankers and saying, OK, these are some of the additional products you should add to your portfolio. And yes, we can add those products today, which can then be further enabled from a servicing standpoint down the road. That's one way. And we continue to look at those opportunities as well. And then the second set of opportunities is where we are looking at how can we get more services or software that is add on to what we are trying to do. And that can, again, accelerate our development efforts or go to market instead of having teams develop it for months and months.

25:58Now we can certainly own those businesses or own that product development, which can accelerate some of the service attach. So both the areas, we are also looking at it from an external standpoint.

26:08Chandradev Mehta:I want to pick on you because you have half a career in banking side and half in-house corp dev. When you get a pitch through the banker, and sometimes you can get it where they land the pitch, and sometimes it's completely off in left field. Walk me through that. How can a banker really nail the pitch down so it's actually like on point and really gets your interest versus when they do wrong? I've seen lots of bankers being on at least on this side. And as you can imagine, the organizations I've been with have been heavily banked. So you can see a range of bankers in terms of how they think about it.

26:36One key element that differentiates good bankers from others, I feel, is folks that know your business and have given thought about why certain things make sense. You have these bankers come in and have 50 page decks with 20 targets on it, just throwing whatever out there and saying, OK, whatever stakes, we will take it. And then there are bankers that come in with three ideas. And but those are the three ideas that make real good sense for you. And then the second element that differentiates good bankers from others is having an angle into those ideas. And everybody knows the companies out there, but what is your angle?

27:06What is your ability? What is your understanding of how the management team, how the board is thinking about it? Because unless you have that kind of engagement and understanding, it is just tough to differentiate yourself. The good bankers versus the not so good ones, I would say, are the ones that know the companies well. They may only know certain companies, but they know which companies they know well. They know them really well. They know how the management team is thinking, how they would entertain or not entertain an approach. Why are they the right fit for us? Because they understand our strategy pretty well.

27:37Sometimes the good bankers will also push us on our thinking. They're like, okay, you have not thought about it this way or you have not thought about it this way. And that also sometimes we would appreciate because we like to be challenged. And I like to sit there and say, okay, how can I be challenged on my thinking? And I'm open to ideas. And good bankers will try to push you on your thinking for the right reasons. And then that's what differentiates as well. So these are some of the reasons I would say you can put bankers in one category versus another.

28:00Chandradev Mehta:Bottom lines go very narrow and deep. I'm curious, if you were to go back to banking, how many companies would you try to cover? Yeah, so see, that's another thing too. I mean, when you have to cover a broader set to have an understanding of the companies, but on the same token, you also want to make sure that which are the top eight or 10 companies that you really want to spend time on and be their trusted advisor because you can't be a trusted advisor to 20 companies. It's just not possible. whether it's five, whether it's eight, pick your number. But you want to understand those companies really well.

28:28You want to spend time on them. So you have to make bets. I go back into banking. You have to make those bets of whatever the seven, eight companies that I want to spend time on, mainly because I have a better understanding of that business. I have a better understanding of how they think about it. I have a better understanding of that space and what they can do in that. And I have those unique capabilities. And that's why those companies make sense for me, not just because they are the seven companies I found off the list. Spending time on thinking through where you want to spend time in banking is super critical, especially in today's environment where it is so heavily bagged and everybody is talking to everybody.

29:01Chandradev Mehta:You got to know the whole space and then pick your five to 10 companies to go deep in. Let's talk about valuation. What moves valuation when you go from IOI to close? What are the red flags that tell you to stop? It all comes down to strategy in my mind. You evaluate the opportunity early on. You say, okay, these are my must-believes and this is why I would do this. And then you test it out after your IOI in certain ways and say, okay, these are my must-believes I had said. Am I still on track to believing in those? Can I make a difference in those? Are those still my challenges and I can risk mitigate them?

29:37And if the answer to all of that starts to becoming yes, then I think that's the deal that you want to do. But if the answers are still, I don't know, it is probably still risky. I can't mitigate it. I still can't have this must-believe in my pocket, then I think that is a deal that you should pass on. And that's where the red versus green flags come in. And you get to know some of it after you submit an IOI through engagement with the management. You get to meet them. You get to understand them, understand the business. You also get to review the diligence in a lot more detail. And you basically start answering your questions to make sure that it clicks.

30:10Now, if there is a lot more value that you can create than you initially thought, then potentially there is a way to get higher on value. But then also it comes down to process dynamics and everything. But again, that's something that you are able to create a lot more and that you start to become even more interesting because now you have better returns on your investment than you earlier thought. But the reverse could be true as well, where you struggle to even meet your existing ROI requirements that you initially thought. And it might be even more challenging. You may have to invest more capital.

30:38You may have to take on more risk and still may not be able to get there. and that's where you should decide to move on. Because if it doesn't check your boxes from a strategy and a value creation standpoint, then any price you pay is not going to get you there.

30:52Chandradev Mehta:So it sounds like even going from initial look, either IOI to LOI, you're essentially trying to validate your thesis. And then when you go from LOI to close, you're trying to validate your actual execution on the deal. Yeah, absolutely. That execution and integration phase should start right after your IOI as you get into the diligence phase because you want to start testing that alongside and saying, okay, these are the value synergy drivers or synergy levers we have been talking about. Are we still on track of it? How are we going to achieve them? What do we need to do from a function standpoint?

31:26What are some of the things that we need to start tracking? Who do we need to bring on board? So that integration phase should also start ramping up as you get deeper into the diligence before you get to a final bit stage. By the final bit stage, you should have a pretty clear idea on your integration model, your value creation drivers, your path to getting there, timing. So all of that should be very crystal clear by the time you get to a binding bid, because once you have the binding bid in phase, then you're just moving closely towards getting to a transaction signed. And then once it's signed, and hopefully it gets closed soon enough, then you are on your own to integrate.

32:01If you're not ready by then, it just becomes more and more challenging.

32:04Chandradev Mehta:So LOI, you have an integration thesis. And then when you go through all your confirmatory diligence, you're still thinking through integration, but again, you're validating the execution of your ability to actually execute all those plans that you're going to do post-close. Absolutely. So that's why you need to name your integration leader early on, make sure that they have a buy-in into what you are looking to do, and they own it. Because if they don't own it, then it'll just be something that you give it to them later on and they may or may not be able to deliver on it. You don't own that. So that's why bringing them early on, defining their role and giving them that accountability and responsibility to be able to create that game plan.

32:42That becomes super important because then they own it and make sure that they deliver on it post-close.

32:47Chandradev Mehta:They're describing a very buyer-led M &A approach. Strategy leading your approach to source proprietary deals and then the execution. You're constantly, I have a thesis on how you're going to integrate and then you ultimately continue validating it, building your integration plan through all the confirmatory diligence. Very buyer-led. I'm curious about your approach between proprietary deal versus an auction deal where a lot of times you got some very, very tight timelines to really force certainty to close and optimal pricing. How does your approach differ between those two scenarios as a proprietary deal when there's more flexibility in timeline versus an auction where it's highly compressed timelines?

33:25By being on the buy side, you mean?

33:27Chandradev Mehta:Yeah, exactly. In a competitive deal process, you need to be crystal clear that's an asset you really want and that's an asset where you can really make a difference and create a lot more synergies. That conviction has to be pretty solid for you to be aggressive in a process. In organizations that I've been, and my philosophy has also always been that you have to be disciplined and not get carried away in those processes because it could get crazy at times. And at that point, you need to know when you need to walk away. And you need to know your walkaway points and walkaway thesis. And if that's where it hits, then I think that becomes the right answer.

34:00But doing a deal for deal's sake is never a good idea. Making sure that it is aligning with your thesis. Now, the process sometimes moves at a pace where it is dictated and you have to match up to the process. And so if the deal is the right deal for you, if it's the right opportunity, then you obviously want to match up to it. And we have capabilities to be able to move faster if there are requirements. I don't think that has been a limitation that I've seen in any instance. But you have to be careful on why you're doing that deal and not get carried away because of the process dynamics. Your deal thesis has to be pretty intact.

34:29Chandradev Mehta:Is it easy to get carried away? Sometimes it could be. You know, people get emotional at times when the deal is that close and you don't want to lose a deal over one or two terms. But I've seen deals getting not done because there are some sticking points that just couldn't get through. And it all comes down to risk allocation. At the end of the day, it's all risk allocation and value. You have to balance both. And if the risk allocation is not in one party's favor with value being in the other party's favor, I think it just makes it challenging for whoever is trying to get a deal done. As long as you can get to a win-win with appropriate risk allocation and value measurement, everybody comes out okay.

35:04But at the end of the day, like I said, it all comes down to risk allocation and how you define that.

35:08Chandradev Mehta:Having strong discipline, knowing when to walk away. Speaking of, what are the biggest risks when doing environmental deals? Obviously, environmental liabilities can blow up a chemical deal. But what do buyers miss early? And when does it usually surface? Doing a lot of chemical deals. Environmental is obviously top on my list a lot of times. I just want to make sure there are no environmental or asbestos liabilities in certain cases and things of that nature. So all of that is an early checkmark when doing chemical deals. How do you kind of risk mitigate that? That's where the question becomes, who takes that risk?

35:41Some of it is known, some of it is unknown. Some of it is because they haven't tested it, they don't know what it is. But what if they test? Then what happens? Who takes that risk? Do you want them to test? Do you want to know it? Do you don't want to know it? A lot of those things comes down to, again, risk allocation. And I have done different methods where you can do a sliding scale, you can do a cap on exposure, different ways to kind of skin that. But you need to know early on on who is going to take that risk. Why are you taking that risk? Are you the best party placed to be able to handle that risk going forward?

36:14Because sometimes if you are going to own that business, only you can mitigate that risk. The seller cannot. And in that case, who pays for it? How do you pay for it? What if it goes beyond a certain dollar threshold, things of that nature? Different ways to approach it. Like I said, sliding scale or gap, or sometimes it is indemnification. You can probably get through that too, but different ways to kind of approach it.

36:36Chandradev Mehta:Yeah, essentially quantifying the risks that you're taking so you know what you can handle. Hey, we haven't talked about any deals. Can we share some deal stories? Like any examples of deals that really tested you out? Every deal is a different deal in different ways. And sometimes I feel that the smaller deals are really hard to execute compared to the larger deals because in larger deals, you always find that everybody's focused on it. Everybody's looking to find a solution. Whereas smaller deals when I have done, especially being at larger companies, trying to sell assets that are small, are relatively noise in your system.

37:09But the buyer, for them, it is like one of their biggest deals that they're doing. I had worked on a transaction where we were selling a small business from a portfolio. And for the buyer, every dollar counted. And for us, we wanted to just get it done with. In that circumstances, you have to be very careful because again, you don't want to give up value, but on the same token, also manage risk on your side. What is the priority on your front? Value may not be a priority for you. The risk is a higher priority that circumstances given the deal size. That's how we kind of ended up doing that. We ended up giving up value because we wanted to manage our risk.

37:42And then that's what you need to make a decision on. But those kinds of deals test you because the buyer wants to check every box and you just don't have that bandwidth to do it. And you just keep on dripping on value because every time the buyer doesn't find something that they want or they find something different, it impacts value. You end up giving a lot more value than you initially intended. And you need to know at what point you need to stop or at what point you need to trade risk for that value. And if that trade is not happening, then also need to walk. And one of the deals, like I mentioned, had a lot of that components in it where a lot of it, we did not even know what we owned because it was such a small business in our broader portfolio.

38:18But the buyer, for them, like this was their only business. They knew our business much better than we did. And that's always a tough place to be in when you're trying to negotiate a deal where they know much better than you do. They have a better leverage in that system. So it was challenging, but I had to quickly learn the business myself, get up to speed and understand it much better. Understand the dynamics. Also, prioritize what is important for us. And risk allocation was way more important than losing on value. And that's what we decided. And that's how we structured the transaction. and it also took about six months to execute on that transaction, which again, for a smaller deal, you are tying up a lot of resources and it just makes it more and more challenging within your larger organization, which was another problem that we had to grapple with.

39:01Chandradev Mehta:Is it the challenge that when you do the smaller deal that it's like getting that level of focus and people's attention to it, where they're just like, oh, it's like a tiny little$10 million company, which is nothing compared to... That's exactly right. If you're like a$10 million company, I have a billion dollar business to run. I don't have time for this$10 million deal. Well, okay, that's fine. But if you don't pay attention to it, you are going to give up a lot of value. You're going to give up risk or you're going to take on more risk and you don't want to be stuck in that situation because they will read that contract and they'll continue to follow that contract and they'll keep coming after you.

39:32And you don't want that. You need to pay attention to be able to get it done. That's how it becomes more challenging. For larger deals, everybody is willing to spend time because they know there is a lot more value that they can get out of it. But for a$10 million deal in a billion dollar portfolio, it's a rounding error.

39:45Chandradev Mehta:That makes it tough, is getting the right resource allocation, the attention, focus. Anything went well on that deal? Once we realized what is important for us and we wanted to get it done by a certain time, we wanted to make sure that we managed some of our risk. And as long as we communicated that and we gave up on value, we would get a deal done. But it took us some time to get there. Yeah, having discipline on the timeline and then ultimately somebody had to take ownership. Yeah, because sometimes in those kind of situations, the noise and the management distraction is just too much of a value destruction for you that giving up value on the deal itself is probably easier if you can get the deal done quickly so your management team can focus on what really matters to you as a company.

40:26That becomes a priority for you and that's what we decided to do.

40:29Chandradev Mehta:Pretty cool. Do you have any other deals that you've been most proud about? There are a lot of deals that are good deals that I worked out well. At Lionel Bazel, we did the SaaShole transaction which has probably been one of the best deals in the company's history. It was a great transaction because it was a good fit for both companies. Lionel didn't have a new cracker in the US. Sasol had a new cracker. They needed the right partner. We were able to provide the right partnership and structure the deal in a manner which was a win-win for both parties. And both the parties have benefited significantly from it.

40:56So there are some deals that end up being a win-win for both which come out pretty well. That's what you want to look for when you're doing transactions where one plus one equals four and both parties benefit from it more so than just one winning and one losing.

41:09Chandradev Mehta:Good strategy on it. Sounds like both sides were motivated to get this deal done and it ended up being a strong value driver. What was the challenges? What were the hard parts or the surprises that came off the deal that actually made it hard to do? No deal is easiest. That's what I'm trying to get to. Exactly. All the deals are challenging, whether it's the value question or whether it's the question on governance and ownership, who is going to do what and what each party brings. And that was more of a partnership or a JV type of a structure. So governance became important. Who is going to do what?

41:42How are we going to drive long-term value creation? Things of that nature became a lot more prominent than the value itself.

41:49Chandradev Mehta:So this JV changes the dynamics quite a bit. Because now all of a sudden you have a huge emphasis on governance. And then also you got to definitely think a lot more long-term because it's almost like the marriage. It's like, I would be together, but maybe things might not work out. I only got to break up. Especially when you're doing JV, sometimes you have to talk about divorce. When you're talking about marriage, it's equally important. So that's why JVs are not easy to execute either. The governance part, like how does that end up working out? You end up with people from both sides, but is there like an approach to figure out who's going to do what or how do you choose between people?

42:19Yeah, that's right. There is a whole theory in terms of how do you structure. The governance rights are one of the keenly negotiated ones in a joint venture. Who is going to do what? How do you escalate? How do you make decisions? Who has the veto rights? If one party doesn't agree, what happens? Who is going to fund? Funding becomes an important element. And what if one party wants to fund, but the other party doesn't want to fund? Who takes that risk? What happens to the equity ownership in that scenario? So governance rights and governance terms are one of the only negotiated points. Again, all boils down to what each party brings to the table.

42:52What is their motivation? How long are they planning to stay in there? What are they looking for? Are they looking for cash? Are they looking for more involvement in operations? Are they looking for more deeper things than that? What is their long-term strategy with their business? and how does this fit into it? Is this more of a cash generation for them versus a long-term strategic pivot? Because then that approach will be very different here. And then also, how do you bring in more independent directors that can break the tie in certain cases? There is no one JV structure that works, but these are some of the points that get keenly negotiated in that transaction.

43:25Chandradev Mehta:Sounds like a whole topic for another podcast interview, my friend. Yeah, joint ventures are a whole different discussion to do. At least we got a little teaser on it. Give me the principles. You spend 10 years of banking, 10 years in corp dev role. What are your big staple principles when it comes to executing M &A today? My main principle is it has to fit with the strategy, has to be fully aligned with the strategy. You need to know your must-believers and your key considerations on why you're doing the deal and why you would not do the deal. And then staying disciplined on execution and making sure that you are paying the right price, you are getting to the right terms, you are making sure that the integration thing is very well defined and taken care of.

44:02Those are the three kind of main value drivers from my standpoint as I look at transactions. That's in my mind the right way to approach deals and getting things done, which makes sense for companies long term.

44:13Chandradev Mehta:Can we talk a little bit more on the execution? If you can unpack that a little bit, it sounds like there's stakeholders, but you have those things you described, why we're doing the deal. Then also align the stakeholders. We obviously talk about so much around the integration, the building thesis, and then the actual planning and execution of it through the deal process. We talk a little bit more about how do you actually line those people in and keep them aligned. You mean the integration people? Yeah, or just general, all the stakeholders that you're going to have to manage through this deal process.

44:40I think that's why regular updating, communication, making sure that we continue to test our deal thesis. We continue to drive our engagement with our partners, whether it's commercial, whether it's supply chain, procurement, functional guys, finance, and making sure that we are bringing the team along as we proceed. It's not like me going and working in the backyard and getting a deal done and then telling them what it is. It is more about bringing everybody together and continuing to test each other, push each other in terms of their thinking, making sure that we are testing appropriately on the value drivers, making sure we are testing appropriately on timing.

45:17Also making sure we bring in the right leadership when it comes time to integration. Who is going to be the right integration leader? Why are they the right person? What can they bring to the table? How are they motivated? Do they have the right team with them to do this? Things of that nature. So all of that becomes important, but you need to be able to manage each of your stakeholders. And in larger companies, board also becomes important. So sometimes in larger transactions, how do you bring the board along as well instead of just telling them at the last minute? You need to keep them updated, make sure that they have bought into your deal thesis, they have bought into your value drivers and have a better understanding.

45:49So when it comes time for final approval, they're already mostly there. Bringing along not only your team, your leadership team, but also the board becomes important.

45:59Chandradev Mehta:Awesome. I got it from the notes from the last conversation. The two are bringing the right people early, get the consensus buy-in so you can plan integration early, which we touched on. And then how do you drive IT integration, which tends to be the longest pole in the tent? IT, like I said, is also an important element of it because it's the backbone of a lot of companies. Everything is driven by IT. Having the right set of tools, having the right set of systems, making sure that they're aligned with what you are having. One of the companies I had looked at had so many of the SAP versions on that company because they hadn't integrated all the businesses that they had bought and ended up having different SAP systems.

46:32And how do you then take that and then integrate that? It takes a whole new effort in itself, given how technology and IT are important for every company now that they are fully vetted as you evaluate because that might require investment, that might require time, which will eat into your ROI and value returns. You need to be able to categorically identify them early on so you know how much you need to invest to bring these IT systems on par up to what you're looking to do.

46:59Chandradev Mehta:One of my favorite topics is like getting deals actionable. You got a lot of experience doing this. Can you tell me like what are your sort of tips and tricks in getting a deal actionable? A lot of it comes down to timing. You can keep pushing for it at times. Sometimes it comes down to when the seller is ready, they're ready. But as I look at it, cultivating and engaging with the potential targets is an important exercise as part of corporate development. And you need to be able to get in front of them, tell them your thinking, your thesis, how are you going to create value combining the businesses?

47:29How are you going to maintain the legacy of their business, especially if it's a family-owned business, they want to see that? And then why does one plus one equal four? And you continue to harp on that thinking, harp on that thesis, show them the progress that you have made as part of your journey. And then you have to sometimes wait for the timing to be right. That's what it comes down to, but you need to have a more regular engagement and cultivation dialogue with these targets so you are on top of their mind. And when they decide to sell or when they decide to do something, you want to be one of the first phone calls that they make.

47:59Chandradev Mehta:I like that. Obviously, building trust is underpinning on all this stuff that they got to like you and trust you enough to want to do business with you. But you hit it. Here's a sort of view of why this deal makes sense for you, but then also getting their take on it, understanding what they want. I like how you mentioned continuing the legacy, which I feel like it's overlooked. Like there's some clear drivers that they have. And then what is the actual broader scene? Yeah, sometimes they want to keep their headquarters the way it is. They don't want to change that. They don't want to have the people that go because they have been there for 30 years, whatever it is.

48:30A lot of that has to be carefully discussed and evaluated and managed.

48:36Chandradev Mehta:Do you find that that these like seller would have these kind of assumptions? Like, oh, this is a big corp. They're going to come tear our business apart. We don't want to do that. All the time. They do that all the time. And that's why it becomes even more important if you're working for a large company to be able to convince them that, look, we are not going to do that. The best way to do that is to demonstrate to other examples, if you have them, even better. But if not, then that becomes challenging because they are not going to just believe you on your word. And that's why it takes time to build that trust.

49:03Chandradev Mehta:You got to take time, break bread with them so they trust you. Then you can say, hey, look, we would have a different approach. Or maybe there are some trade-offs or something where it's not going to be everything that we're going to take your company apart. And then there's obviously some creative value creation. Obviously, you're trying to expand. We can help you expand faster in some of these areas. You mentioned cross-culture earlier that you've done deals in Europe, Asia. I'm just curious because I feel like that makes it exponentially more complicated. Because then if you're in the US, you go take a flight and go spend time with a person, go have dinner.

49:31Chandradev Mehta:But if you're doing a... That's a long flight. Yeah, no, it's challenging, especially in Europe where there is a lot of family-owned businesses and going and spending time there. It's a conscious exercise. Building trust is so different. I've worked on some deals in Europe where it's just, they don't care. They don't want to talk to you. They don't want to spend time with you. They just want you to send an offer. And it makes it difficult because they can have been this management team. I don't know what that looks like. You can't convince everybody out there either. So some of it is, it just may not happen at a year.

49:55But at least you can try. Sometimes Germans just want to talk to Germans. You have to find a German on the team to do it. And even in Asia, when I spent time there, it was China was a little tough because they wanted to talk to Mandarin speakers. I had to have somebody who was more local speaker with me to deliver some of that message, break bread with them, have more engagement. So you have to understand and be able to attune to those requirements.

50:16Chandradev Mehta:Is your first impression everything? Do you ever have a meeting with someone and this seems great, we'll probably get a deal done at some point versus I don't think we'll ever get a deal done. I'm going to write this off. I've seen both and both have changed in one way or another. Sometimes you feel like I can get a deal done and we get to the deal and it doesn't get done. Sometimes you feel there is no way these guys are going to sell, what is going to happen and then you get it done. In my mind, it all comes down to timing. It all comes down to what is right then, but you just have to keep at it.

50:43Chandradev Mehta:So it's like a counter-discipline. You can't be purely emotional on this stuff. There's a huge factor in doing deals. Sometimes there is chemistry as well, but chemistry only goes so far and there's value. There are other aspects to it. So it all depends. These are very helpful tips. I gotta ask, what's the craziest thing you've seen in M &A? Everything is crazy in terms of whatever you look at it. Yeah, look, I don't think there is one thing I can define as crazy, but it's the process, the grind. You haven't seen anything crazy you in a deal where it just totally surprised you and shocked you?

51:10One of the smaller deals we were doing, we thought we were negotiating the deal and they just sent us a signed contract and said, that's what we have. And I'm like, okay, but we haven't even barely negotiated any of this. But that's how they wanted to do a deal. We had to work around it, manage it differently and all that. So you see that kind of strange things all the time.

51:26Chandradev Mehta:The variables, no two deals are alike. Hey Dev, I appreciate this conversation. It's been helpful, helping me become a better M &A scientist through every interview we do. No, happy to be here. And thank you for inviting me. It was a good conversation. Hopefully I was able to give you some tidbits and new answers that the viewers and your audience might find useful. Glad to have a conversation. It's a topic that is close to me and I've spent a lot of time on it. And again, it's an exciting topic. So always happy to be part of it. I appreciate it. Thank you. And if you're still listening to this podcast, my fellow scientists, you're pretty much an M &A mad scientist at this point if you get through the whole podcast interview.

52:04Chandradev Mehta:Love to hear the feedback. connect with me on LinkedIn. I got my privacy guard off of there. So I get a bunch of spam coming in every day. So make sure you put a little note that you listen to the podcast. I'll love to connect with you. Open to any feedback. There's topics that you're interested that we haven't covered yet. I like getting those suggestions. And also improve this format, criticism, questions I should be asking and I'm not. I look forward to hearing from you. Until next time, here's to the deal.

52:41Chandradev Mehta:Thank you for taking the time to explore the world of M &A with our podcast. We love hearing feedback. Tag us on a LinkedIn post, add a review on Apple Podcasts. We'd love to hear from you. If you need help standing up an M &A function or optimizing one that you already have, we're here to help. And if we can't help you, we probably know someone that can. You can reach out to me by email, Kisan, K-I-S-O-N, at mascience.com, or you can text me directly at 312-857-3711. If you just want to keep learning at your own pace, visit mascience.com for a lot more content and resources. That's where you can also subscribe to our newsletter.

53:26Chandradev Mehta:Again, that's mascience.com. Here's to the deal.

53:57Chandradev Mehta:Thank you.

From the publisher

Chandradev Mehta, SVP Strategy and Business Development at Hexion Inc.

Chandradev Mehta, SVP Strategy and Business Development at Hexion Inc., breaks down how a commodity chemical company uses M&A to transform into a technology-enabled, chemistry-as-a-service business. He covers the acquisition of an AI and MarTech company, the build vs. buy vs. partner decision framework, integration planning discipline, banker selection, small deal execution, and JV governance.

What You'll Learn

  • How to build a genuine build vs. buy vs. partner framework  and when each is right
  • Why buying a commercialized or near-commercialized business changes your risk profile in ways that building from scratch can't (and never will)
  • How Chandradev structures must-believes to maintain valuation discipline in competitive processes
  • Why integration planning needs to start at IOI, not post-close
  • What separates a banker worth your time from one running a numbers game
  • Why small deals are frequently harder to execute than large ones (and how to protect against organizational deprioritization)
  • How to negotiate JV governance before you need to unwind it

____________________

If you're building an M&A capability from scratch or trying to get your team aligned on deal fundamentals, the M&A Fundamentals Track on DealPilot covers the full deal life cycle in roughly five hours, including vocabulary, process, and both sides of the table. Access it when you become an M&A Science member.

____________________

This episode is sponsored by DealRoom

DealRoom's Buyer-Led M&A™ Summit is Back!
Join me at the summit on May 20, a free virtual event hosted by DealRoom covering AI, pipeline, diligence, and integration across the deal lifecycle. Sessions run 11:30 AM to 1:30 PM ET. 

Register here: https://hubs.ly/Q0496h-s0

____________________

Episode Chapters

[00:00] Introduction

[04:41] From Investment Banking to the Principal Side

[10:24] Using M&A to Transform Hexion

[11:01] Build vs. Buy vs. Partner Framework

[16:42] What Chemistry as a Service Actually Means

[23:43] Sourcing Deals: Push and Pull Model

[26:24] What Makes a Banker Actually Useful

[29:12] Valuation Discipline and Must-Believes

[36:21] Environmental Risk in Chemical Deals

[36:46] Why Small Deals Are Harder Than They Look

[41:21] Joint Ventures: Negotiate the Divorce First

[43:25] Execution Principles and Stakeholder Alignment

[47:08] Getting Deals Actionable

More from M&A Science

All 205 episodes
How M&A Turns a Chemical Company Into a Tech BusinessM&A Science · 54 min
Listen in VO